24 25 26
May 2018
21 June
Industry Breakfast

THE NEXT STAGE IN DELIVERING A MORE EFFECTIVE HEALTHCARE SYSTEM

08:00-09:30 Pavilion 5, Business Breakfast Hall 5.4
The question of how to create a more effective healthcare system remains a pressing issue for all sectors of Russian society. As with most developed countries solutions lay in achieving the correct mix of public-private involvement and incentives. Which models of public-private cooperation should Russia look to? How can barriers (whether economic or related to clinical care) be addressed in the first instances? How can greater interaction be encouraged between consumers and providers of medical services lead to a more efficient healthcare system?
Moderator:
Panos Kanavos, Reader in International Health Policy in the Department of Social Policy, London School of Economics (LSE) and Programme Director of the Medical Technology Research Group (MTRG) at LSE Health
Panellists:
David Epstein, Division Head, Novartis Pharmaceuticals, Member of the Executive Committee, Novartis
Patrick Flochel, Global Pharmaceutical Leader, Ernst & Young
Mark Kurtser, Chairman, Presidium of the Moscow Society of Obstetricians and Gynecologists; Chairman of the Board of Directors, Group of Companies Mother and Child
Mark Mallon, Executive Vice-President for International Markets, AstraZeneca
Simon Matskeplishvili, Chairman of the Echocardiography Section, Russian Society of Cardiology; Chief Scientific Researcher, Bakulev Scientific Center for Cardiovascular Surgery of the Russian Academy of Medical Sciences
Vladimir Nazarov, Deputy Director, Institute of Social Analysis and Forecasting of the Russian Presidential Academy of National Economy and Public Administration
Vikram Punia, President, Pharmasyntez JSC
Vladimir Shipkov, Executive Director, Association of International Pharmaceutical Manufacturers
Veronika Skvortsova, Minister of Healthcare of the Russian Federation
Paul Stoffels, Worldwide Chairman Pharmaceuticals, Chief Research Officer, Johnson & Johnson; Member of Executive Committee, Johnson & Johnson
Michael Warmuth, Executive Vice President, Established Pharmaceuticals Division, Abbott Laboratories
Ray Yip, Director of the China Program, Bill & Melinda Gates Foundation

Highlights

Healthcare is not only the treatment of disease, but also prevention, management and lifestyle.

Michael Warmuth
Executive Vice President, Established Pharmaceuticals Division, Abbott Laboratories

The main process currently underway for creating a new Russian healthcare model boils down to effectively separating the functionality of medical care from the infrastructure by creating an open competitive environment for infrastructure with all types of ownership. What we want to see is a phased replacement of state infrastructure with well-developed private, departmental and various other types of infrastructure.

Veronika Skvortsova
Deputy Minister of Health and Social Development of the Russian Federation

It is so important for Russia and all of the countries involved (in the G20) to see healthcare as an investment instead of healthcare as a cost, and healthcare as an economic driver for the world.

Paul Stoffels
Worldwide Chairman Pharmaceuticals, Chief Research Officer, Johnson & Johnson; Member of Executive Committee, Johnson & Johnson